ANEXO IV VALOR ESTIMADO POR LOTE

440.480. 19,313624. 8.507.265,10 €. 23. 200 Lopinavir / 50 ritonavir. CPV 33690000-3. CPA 21.20.1. Comprimidos. 8.470.967. 2,740313. 23.213.100,99 €. 24.
25KB Größe 16 Downloads 75 vistas
ANEXO IV VALOR ESTIMADO POR LOTE Lot e

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

M EDI CAM ENT O Sa q u i n a v ir CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Fo s a m pr e n a v ir CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 A t a za n a v ir 1 5 0 m g CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 A t a za n a v ir 2 0 0 m g CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 A t a za n a v ir 3 0 0 m g CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Ti p ra n a v i r CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Da r u na v ir CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Abac avir CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Te n o f o v ir d is o p r o x il CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Em t r i c it a b in a CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Et ra v iri n a CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Ril p ivi rina CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 En f u v irt id a CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Ra lt e g ra v i r CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 M a ra v i ro c 1 5 0 m g CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 M a ra v i ro c 3 0 0 m g CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Do lu t e g ra v i r CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 L a m i v u d in a /a b a c a v i r CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Em t r i c it a b in a / t e n o f o vir d i s o p r o x il CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Em t r i c it a b in a / t e n o f o vir d i s o p r o x il / e f a vi re n z CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1

M a gnit ud

N º e st im a do de

Pre c io unit a rio

de m e dida

unida de s

sin I V A e n €

V a lor e st im a do m á x imo sin I V A e n €

M i li g ra m o s

8 9 .8 8 9 .9 2 2

0 ,0 0 3 2 3 3

29 0 .6 1 4 ,1 2 €

M i li g ra m o s

4 7 9 .1 2 5 .7 5 8

0 ,0 0 6 4 3 5

3 .08 3 .1 7 4 ,2 5 €

M i li g ra m o s

3 .0 8 9 .2 9 2

0 ,0 3 8 6 8 7

11 9 .5 1 5 ,4 4 €

M i li g ra m o s

1 7 8 .4 2 8 .4 5 4

0 ,0 2 9 0 1 6

5 .17 7 .2 8 0 ,0 2 €

M i li g ra m o s

5 8 1 .2 4 2 .7 6 4

0 ,0 3 8 6 8 7

2 2 .48 6 .5 3 8 ,8 1 €

M i li g ra m o s

1 9 .3 6 4 .2 9 6

0 ,0 2 1 4 6 6

41 5 .6 7 3 ,9 8 €

M i li g ra m o s

5 .5 3 7.9 0 2 .8 5 5

0 ,0 1 4 4 7 1

8 0 .13 8 .9 9 2 ,2 1 €

M i li g ra m o s

1 9 6 .0 7 1 .1 0 0

0 ,0 1 1 1 6 0

2 .18 8 .1 5 3 ,4 8 €

M i li g ra m o s

8 1 5 .9 2 3 .5 4 2

0 ,0 3 2 3 4 2

2 6 .38 8 .5 9 9 ,2 0 €

M i li g ra m o s

1 3 .2 1 0 .9 7 8

0 ,0 1 9 4 8 9

25 7 .4 6 8 ,7 5 €

M i li g ra m o s

8 6 6 .2 9 2 .6 9 5

M i li g ra m o s

9 .2 0 4 .0 4 1

M i li g ra m o s

5 2 2 .2 7 6

M i li g ra m o s

2 .3 3 1.1 5 2 .4 0 3

M i li g ra m o s

5 5 .1 8 5 .6 6 6

M i li g ra m o s

1 4 1 .4 5 4 .7 3 9

M i li g ra m o s

4 0 .1 5 1 .2 7 1

Co m p rim id o s

5 .1 7 4 .5 3 0

Co m p rim id o s

8 .6 7 2 .6 8 8

Co m p rim id o s

6 .6 0 7 .5 2 5

Co m p rim id o s

3 .1 0 5 .6 8 9

Co m p rim id o s

4 4 0 .4 8 0

Co m p rim id o s

8 .4 7 0 .9 6 7

Co m p rim id o s

7 0 .9 6 3

0 ,0 2 7 0 8 5 0 ,2 9 0 5 1 0 0 ,1 9 7 3 4 8 0 ,0 1 6 0 0 0

2 3 .46 3 .5 3 7 ,6 4 € 2 .67 3 .8 6 5 ,9 5 € 10 3 .0 7 0 ,1 2 € 3 7 .29 8 .4 3 8 ,4 5 €

0 ,0 6 4 5 6 2

3 .56 2 .8 9 6 ,9 7 €

0 ,0 3 2 2 8 1

4 .56 6 .3 0 0 ,4 3 €

0 ,2 6 3 0 7 0

1 0 .56 2 .5 9 4 ,8 6 €

8 ,9 3 7 0 7 3

4 6 .24 5 .1 5 2 ,3 5 €

1 1 ,6 8 9 0 5 5

1 0 1 .37 5 .5 2 7 ,0 3 €

1 6 ,8 8 5 3 8 2

1 1 1 .57 0 .5 8 3 ,7 0 €

1 9 ,1 1 7 3 3 3

5 9 .37 2 .4 9 0 ,8 1 €

1 9 ,3 1 3 6 2 4

8 .50 7 .2 6 5 ,1 0 €

2 ,7 4 0 3 1 3

2 3 .21 3 .1 0 0 ,9 9 €

1 ,3 7 0 1 5 6

9 7 .2 3 0 ,3 8 €

1 ,0 3 8 5 7 8

65 6 .8 7 6 ,7 0 €

1 9 ,1 8 2 1 8 8

1 1 .33 1 .4 7 4 ,7 4 €

Em t r i c it a b in a / t e n o f o vir d i s o p r o x il / r i lp i v ir i n a 21 22

CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Em t r i c i t ab i na / t en of o vi r di s op ro x i l / e l vi t eg ra vi r / c ob i c i s t a t CPV 3 36 90 00 0-3 . CPA 2 1 .2 0 .1

2 0 0 L o p in a v ir / 5 0 r i t on a v ir 23

CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 1 0 0 L o p in a v ir /2 5 ri t o n a v i r

24 25 26

CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 8 0 L o p i na v ir / 2 0 r it o na v ir (p o r m l) CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1 Do lu t e g ra v i r / A b a c a v ir / L a m iv u d in a CPV 3 3 6 9 0 0 0 0 -3 . CPA 2 1 .2 0 .1

Mi lil it r o s

6 3 2 .4 7 7

Co m p rim id o s

5 9 0 .7 2 9

5 8 5 .14 6 .4 1 6 ,4 8 €

26